May 11, 2020 / 11:55 AM / in 21 days

BRIEF-Kodiak Sciences Announces Q1 2020 Financial Results

May 11 (Reuters) - Kodiak Sciences Inc:

* KODIAK SCIENCES ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

* Q1 LOSS PER SHARE $0.54

* Q1 EARNINGS PER SHARE ESTIMATE $-0.47 — REFINITIV IBES DATA

* DID DELAY INITIATION OF NEXT SET OF KSI-301 PIVOTAL STUDIES BY ONE QUARTER

* 2022 VISION TOWARDS A BLA FILING IN THE KEY RETINAL DISEASE INDICATIONS REMAINS INTACT

* KODIAK SCIENCES - NOW INTEND TO CONDUCT TWO PHASE 3 STUDIES IN DME, ONE STUDY IN WET AMD, ONE STUDY IN RVO & ONE STUDY IN NON-PROLIFERATIVE DR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below